Functional interferon system is required for clearance of Lassa virus

Journal of Virology

Volumn 86, Issue 6, 2012, Pages 3389-3392

  Yun, Nadezhda E ^a   Poussard, Allison L ^a   Seregin, Alexey V ^a   Walker, Aida G ^a   Smith, Jennifer K ^a   Aronson, Judith F ^a   Smith, Jeanon N ^a   Soong, Lynn ^a   Paessler, Slobodan ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON RECEPTOR; INTERFERON RECEPTOR 1; INTERFERON RECEPTOR 2; UNCLASSIFIED DRUG;

ARTICLE; CELL INFILTRATION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DISEASE MODEL; HISTOPATHOLOGY; INFECTION CONTROL; LASSA FEVER; LASSA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; VIRAL CLEARANCE; VIRUS TITRATION;

ANIMALS; FEMALE; HUMANS; INTERFERONS; LASSA FEVER; LASSA VIRUS; MALE; MICE; MICE, KNOCKOUT; RECEPTORS, INTERFERON;

LASSA VIRUS;

EID: 84863239710     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06284-11     Document Type: Article

References (15)

1. Buchmeier MJ, de la Torre J-C, Peters CJ. 2007. Arenaviridae: the viruses and their replication, p 1635-1668. In Knipe DM et al. (ed), Fields virology. Lippincott, Williams and Wilkins, Philadelphia, PA.
2. Cashman KA, et al. 2011. Evaluation of Lassa antiviral compound ST-193 in a guinea pig model. Antiviral Res. 90:70 -79.
3. Centers for Disease Control. 2004. Arenavirus fact sheet, p 1-2. www-cdc.gov/ncidod/dvrd/spb/mnpages/dispages/lassaf.htm.
4. Fisher-Hoch SP, Hutwagner L, Brown B, McCormick JB. 2000. Effective vaccine for Lassa fever. J. Virol. 74:6777- 6783.
5. Flatz L, et al. 2010. T cell-dependence of Lassa fever pathogenesis. PLoS Pathog. 6:e1000836.
6. Geisbert TW, et al. 2005. Development of a new vaccine for the prevention of Lassa fever. PLoS Med. 2:e183.
7. Jahrling PB. 1983. Protection of Lassa virus-infected guinea pigs with Lassa-immune plasma of guinea pig, primate, and human origin. J. Med. Virol. 12:93-102.
8. Jahrling PB, Smith S, Hesse RA, Rhoderick JB. 1982. Pathogenesis of Lassa virus infection in guinea pigs. Infect. Immun. 37:771-778.
9. Johnson KM, et al. 1987. Clinical virology of Lassa fever in hospitalized patients. J. Infect. Dis. 155:456-464.
10. Kolokoltsova OA, et al. 2010. Mice lacking alpha/beta and gamma interferon receptors are susceptible to Junin virus infection. J. Virol. 84:13063- 13067.
11. Mack EA, Kallal LE, Demers DA, Biron CA. 2011. Type 1 interferon induction of natural killer cell gamma interferon production for defense during lymphocytic choriomeningitis virus infection. mBio 2:e00169-11.
12. Peters CJ, et al. 1987. Experimental studies of arenaviral hemorrhagic fevers. Curr. Top. Microbiol. Immunol. 134:5- 68.
13. van den Broek MF, Muller U, Huang S, Aguet M, Zinkernagel RM. 1995. Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors. J. Virol. 69:4792- 4796.
14. Walker DH, et al. 1982. Pathologic and virologic study of fatal Lassa fever in man. Am. J. Pathol. 107:349 -356.
15. Yun NE, et al. 2008. Pathogenesis of XJ and Romero strains of Junin virus in two strains of guinea pigs. Am. J. Trop. Med. Hyg. 79:275-282.